4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000144
Chairperson & CEO sold 9,500 shares at an average $496.06 ($4,712,580)
- Chairperson & CEO acquired 9,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROTHBLATT MARTINE A · Chairperson & CEO
Table I: Non-derivative
10 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-09-17 | Exercise or conversion : show line 1 in the form 10b5-1 | +9,500 | $117.76 | $1,118,720 | 333,943 | I |
| 2026-09-17 | Sale : show line 2 in the form 10b5-1 | −599 | $493.22 | $295,436 | 333,344 | I |
| 2026-09-17 | Sale : show line 3 in the form 10b5-1 | −1,750 | $494.34 | $865,096 | 331,594 | I |
| 2026-09-17 | Sale : show line 4 in the form 10b5-1 | −1,905 | $495.11 | $943,183 | 329,689 | I |
| 2026-09-17 | Sale : show line 5 in the form 10b5-1 | −2,182 | $496.21 | $1,082,721 | 327,507 | I |
| 2026-09-17 | Sale : show line 6 in the form 10b5-1 | −1,953 | $497.17 | $970,978 | 325,554 | I |
| 2026-09-17 | Sale : show line 7 in the form 10b5-1 | −151 | $497.79 | $75,166 | 325,403 | I |
| 2026-09-17 | Sale : show line 8 in the form 10b5-1 | −332 | $499.10 | $165,701 | 325,071 | I |
| 2026-09-17 | Sale : show line 9 in the form 10b5-1 | −468 | $500.09 | $234,043 | 324,603 | I |
| 2026-09-17 | Sale : show line 10 in the form 10b5-1 | −160 | $501.60 | $80,256 | 324,443 | I |
| Open-market sales · 9,500 sh · avg $496.06 · $4,712,580 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-09-17 | Exercise or conversion : show line 11 in the form 10b5-1 Stock Option | −9,500 | 413,910 | I |
Loading xslF345X06/primarydocument.xml…